Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2010-02-15

European Medicines Agency and Swissmedic agree sharing of information on H1N1 pandemic medicines

View source ↗

Summary

EMA and Swissmedic have agreed to share information regarding medicines used to treat H1N1 pandemic, facilitating coordinated regulatory oversight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications